杂志简称：gen comp endocr
中文译名：《普通与比较内分泌学》
收录属性：scie（2024版）, 英文期刊,
自引率：11.80%
投稿方向：医学、endocrinology & metabolism 内分泌学与代谢
SCI/E期刊基本信息
出版周期：年15期 地区：美国
中科院分区：3区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN0016-6480；EISSN1095-6840
杂志语言：英语
出版国家：美国
杂志官网 联系方式
出版地址：ACADEMIC PRESS INC ELSEVIER SCIENCE,525 B ST,STE 1900,SAN DIEGO,USA,CA,92101-4495
杂志邮箱：
投稿网址：https://www.editorialmanager.com/GCE/default.aspx
杂志官方网址：https://www.journals.elsevier.com/general-and-comparative-endocrinology
出版商网址：http://www.apnet.com
杂志投稿要求
投稿须知【杂志社官方网站信息】
Guide for Authors
General and Comparative Endocrinology publishes articles concerned with the many complexities of vertebrate and invertebrate endocrine systems at the sub-molecular, molecular, cellular and organismal levels of analysis. Although by no means comprehensive, submission of manuscripts in the following areas of endocrine science are encouraged:
• endocrine regulation and interactions in physiological processes ("systems" biology – reproduction, body fluid homeostasis, skeletal and calcium homeostasis; gastrointestinal function; integumentary function; neurophysiology; cardiovascular function etc);
• endocrine pharmacology;
• the role of gene expression in endocrine systems;
• behavioral endocrinology;
• developmental endocrinology;
• growth factors;
• endocrine- environmental interactions;
• immuno-endocrine interactions;
• neuroendocrinology, neuropeptides, neurotransmitters;
• hormonal receptors;
• molecular evolution of hormones and gene families.
Comparative Molecular Analyses
– Genomics
– Proteomics
– Transcriptomics
– Metabolomics
Manuscripts that advance understanding within and between these broad disciplines are especially encouraged.
General and Comparative Endocrinology will consider for publication of research articles that address endocrinology in its widest sense, i.e. both among, and within, living organisms – vertebrate, invertebrate and plant – including their evolutionary antecedents. Original and novel information in acute, and in the longer term, evolutionary adaptive homeostasis are of especial interest to the journal.
The European Society for Comparative Endocrinology, North American Society for Comparative Endocrinology, The Division of Comparative Endocrinology of the Society for Integrative and Comparative Biology, the Asia and Oceania Society for Comparative Endocrinology and the Japan Society for Comparative Endocrinology are affiliated to General and Comparative Endocrinology.
Types of article
Regular article – Full-length original research papers, reporting novel findings in all endocrinology related fields.
Short Communications – these are articles that present a new technique, idea or concept and are typically 10 double spaced pages in length.
Communications in Comparative Molecular Analyses – these are original research manuscripts ranging from 10 to 24 double spaced pages which report studies deploying any kind of "omics" technologies, which are relevant to the endocrine literature (i.e., results of small to high throughput studies). Manuscripts can report the analysis of primary data or in silico analysis or meta-analysis of data deposited in databases and should frame the significance of the data in light of comparative endocrinology and endocrine function.
Review – topics of interest to its broad readership. Review submissions are typically 20-25 double spaced pages in length.
Mini-Review – are focused on a particular topic of interest. Mini-reviews submissions are typically 12 double spaced pages in length.
Editorial – these are typically preface to Special Issues but we welcome suggestions for opinion pieces that discuss issues (scientific, social or political) that affect research in the community. Either type of editorial should be 2 to 3 double spaced pages.
Book reviews – This is a brief essay of 2 double spaced pages critically evaluating the contribution of a recently published book. We also welcome book review essays revolving around descriptions and critiques of a group of published books that serves as springboards for discussions of topics that emerge as one considers overlaps and gaps between the books in question The length should be commensurate with the number of books reviewed (eg. 2 books would be 4 double spaced pages).
Memorials – of notable comparative endocrinologists, outlining their career and indicating their main contributions to the field. The length should be up to 2 double spaced pages and include a photograph.
Special Issues – The journal welcomes proposals for special issues on topics that fall within the scope of the journal. Those wishing to guest edit a special issue should prepare a proposal that:
• Sets out the importance of the area and explains the anticipated contribution of the special issue in advancing understanding in this area
• Identifies papers and authors for possible inclusion in the special issue and an indication of the time-scale in which the special issue could be produced.
Proposals should be sent to the Journal Manager, GCE@elsevier.com
Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
All necessary files have been uploaded:
Manuscript:
• Include keywords
• All figures (include relevant captions)
• All tables (including titles, description, footnotes)
• Ensure all figure and table citations in the text match the files provided
• Indicate clearly if color should be used for any figures in print
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)
Further considerations
• Manuscript has been 'spell checked' and 'grammar checked'
• All references mentioned in the Reference List are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Internet)
• A competing interests statement is provided, even if the authors have no competing interests to declare
• Journal policies detailed in this guide have been reviewed
• Referee suggestions and contact details provided, based on journal requirements
Ethics in publishing
Please see our information on Ethics in publishing.
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Preprint Repositories
General and Comparative Endocrinology accepts submissions that have been previously posted to a preprint server. Authors submitting preprints are asked to inform the editors in their cover letter and identify the site where the preprint is currently hosted. If the author's paper is accepted by General and Comparative Endocrinology, the journal requires that the author update the preprint to link to the final publication in General and Comparative Endocrinology. For more information please visit: https://www.elsevier.com/about/policies/sharing
Preprints
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Author contributions
For transparency, we encourage authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing – original draft; Writing – review & editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following. More details and an example
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Article transfer service
This journal is part of our Article Transfer Service. This means that if the Editor feels your article is more suitable in one of our other participating journals, then you may be asked to consider transferring the article to one of those. If you agree, your article will be transferred automatically on your behalf with no need to reformat. Please note that your article will be reviewed again by the new journal. More information.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases.
For gold open access articles: Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (more information). Permitted third party reuse of gold open access articles is determined by the author's choice of user license.
Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit https://www.elsevier.com/fundingbodies.
US National Institutes of Health (NIH) voluntary posting (" Public Access") policy.
As a service to our authors, Elsevier will deposit to PubMed Central (PMC) author manuscripts on behalf of Elsevier authors reporting NIH funded research. This service is a continuation of Elsevier's 2005 agreement with the NIH when the NIH introduced their voluntary 'Public Access Policy.'
The service will help authors comply with the National Institutes of Health (NIH) revised ''Public Access Policy,'' effective April 7, 2008. The NIH's revised policy requires that NIH-funded authors submit to PubMed Central (PMC), or have submitted on their behalf, their peer-reviewed author manuscripts, to appear on PMC no later than 12 months after final publication.
Elsevier will send to PMC the final peer-reviewed manuscript, which was accepted for publication and sent to Elsevier's production department, and that reflects any author-agreed changes made in response to peer-review comments. Elsevier will authorize the author manuscript's public access posting 12 months after final publication. Following the deposit by Elsevier, authors will receive further communications from Elsevier and NIH with respect to the submission.
Authors are also welcome to post their accepted author manuscript on their personal or institutional web site. Please note that consistent with Elsevier's author agreement, authors should not post manuscripts directly to PMC or other third party sites. Individual modifications to this general policy may apply to some Elsevier journals and society publishing partners.
As a leading publisher of scientific, technical and medical (STM) journals, Elsevier has led the industry in developing tools, programs and partnerships that provide greater access to, and understanding of, the vast global body of STM information. This service is an example of Elsevier willingness to work cooperatively to meet the needs of all participants in the STM publishing community.
Open access
Please visit our Open Access page for more information.
Elsevier Researcher Academy
Researcher Academy is a free e-learning platform designed to support early and mid-career researchers throughout their research journey. The "Learn" environment at Researcher Academy offers several interactive modules, webinars, downloadable guides and resources to guide you through the process of writing for research and going through peer review. Feel free to use these free resources to improve your submission and navigate the publication process with ease.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's Author Services.
Submission
Submission to this journal proceeds totally online and you will be guided stepwise through the creation and uploading of your files. To submit your article please got to https://www.editorialmanager.com/GCE/default.aspx. The system automatically converts source files to a single PDF file of the article, which is used in the peer-review process. Please note that even though manuscript source files are converted to PDF files at submission for the review process, these source files are needed for further processing after acceptance. All correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail removing the need for a paper trail.
Referees
Please submit the names and institutional e-mail addresses of several potential referees. For more details, visit our Support site. Note that the editor retains the sole right to decide whether or not the suggested reviewers are used.